Video
Christopher M. Jones, PharmD, CDR, US Public Health Service, discusses opportunities for pharmacists to reduce opioid prescription rates.
Christopher M. Jones, PharmD, CDR, US Public Health Service, discusses opportunities for pharmacists to reduce opioid prescription rates.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria